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Abstract
Background:  Antiretroviral prescribing errors are common among hospitalized patients.
Inadequate medical knowledge is likely one of the factors leading to these errors. Our objective
was to determine the proportion of hospital physicians with knowledge gaps about prescribing
antiretroviral medications for hospitalized HIV-infected patients and to correlate knowledge with
length and type of medical training and experience.
Methods: We conducted an electronic survey comprising of ten clinical scenarios based on
antiretroviral-prescribing errors seen at two community teaching hospitals. It also contained
demographic questions regarding length and type of medical training and antiretroviral prescribing
experience. Three hundred and forty three physicians at both hospitals were asked to anonymously
complete the survey between February 2007 and April 2007.
Results: One hundred and fifty-seven physicians (46%) completed at least one question. The mean
percentage of correct responses was 33% for resident physicians, 37% for attending physicians, and
93% for Infectious Diseases or HIV (ID/HIV) specialist physicians. Higher scores were
independently associated with ID/HIV specialty, number of outpatients seen per month and
physician reported comfort level in managing HIV patients (P < .001).
Conclusion: Non-ID/HIV physicians had uniformly poor knowledge of common antiretroviral
medication regimens. Involvement of ID/HIV specialists in the prescribing of antiretrovirals in
hospitalized patients might mitigate prescribing errors stemming from knowledge deficits.
Introduction
Medication errors are common, harming at least 1.5 mil-
lion people in the United States every year and costing bil-
lions of dollars annually [1]. These errors can occur at
levels of prescribing, dispensing and/or administration.
Many factors have been associated with prescribing errors,
including: inadequate knowledge of the prescriber; inade-
quate access to information; sound-alike medication
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names; incorrect dosage or dose frequency; inaccurate
adjustment for hepatic or renal impairment; complicated
regimens; and incorrect reporting by the patient [2-5].
Medication errors frequently occur at the time of hospital
admission, mostly due to omission of regularly used med-
ication [6]. Errors in conversion of outpatient HIV medi-
cations to the hospital's formulary-equivalent drugs have
been shown to be associated with moderate to severe dis-
comfort or clinical deterioration of HIV patients [7].
The use of combination antiretroviral therapy (ART) has
led to major improvements in the management of HIV/
AIDS in the developed world and increasingly in the
developing world. A minimum of three agents are typi-
cally utilized in antiretroviral regimens. Even with the use
of external resources, it is difficult at times to precisely
dose antiretroviral medication due to complex drug-drug
interactions and adverse effects.
Successful management of HIV requires close adherence
to recommended ART prescribing guidelines. Antiretrovi-
ral prescribing errors may result in actual or potential
patient harm, including treatment failure, emergence of
resistance and toxicity [3,8,9]. Previous studies showed
ART prescribing errors in HIV-infected hospitalized
patients in as many as 26% of admissions [3-5]. In a more
recent study, at least one error was seen in the initial med-
ication regimen of 72% of HIV-infected patient admis-
sions [7].
With the advent of highly active antiretroviral therapy,
HIV has become a chronic disease, primarily managed in
the outpatient setting by HIV specialists. As a result, non-
HIV specialists working in hospitals may have little occa-
sion to initiate ART and may not be familiar with increas-
ingly complex regimens. In order to discern whether lack
of knowledge and experience might account for antiretro-
viral medication prescribing errors, we conducted a study
to assess the knowledge of physicians prescribing antiret-
roviral medications in hospitalized patients. We hypothe-
sized that general internists would have limited
knowledge of antiretroviral regimens, whereas infectious
disease physicians and HIV-experienced internists would
have adequate knowledge of these medications.
Methods
We conducted an anonymous survey (see appendix 1) at
two community teaching hospitals: Baystate Medical
Center (BMC), a 653-bed tertiary care hospital in Spring-
field, Massachusetts and Johns Hopkins Bayview Medical
Center (JHBMC), a 354-bed hospital in Baltimore, Mary-
land. Both hospitals use a computerized provider order
entry system. Both hospitals have active residencies in
internal medicine, pediatrics and family practice, as well
as fellowship programmes in infectious diseases. The
study was approved by the Institutional Review Board at
each hospital. Two other hospitals originally participating
in the study were excluded due to very low response rate
to the survey: one prior to IRB approval and the other
prior to data analysis. The data from these two institutions
were not reviewed prior to their exclusion.
The survey was sent to all residents, fellows and attending
physicians in the divisions of General Internal Medicine,
Medicine/Pediatrics, Family Practice, Critical Care and
Infectious Diseases at both hospitals. The survey was sent
as a hyperlink in an emailed invitation letter to a total of
343 physicians at both hospitals (210 at BMC and 133 at
JHBMC) between February 2007 and April 2007. Two to
three reminder letters were emailed to the physicians.
The survey, created by the authors using SurveyMon-
key.com (an online survey tool, based in Portland, Ore-
gon), was divided into two sections. One contained basic
demographic questions, including: level of training; cur-
rent position; specialization in Infectious Diseases (ID) or
HIV; number of years elapsed since residency; number of
HIV inpatients seen per month; number of HIV outpa-
tients seen per month; percentage of time spent seeing
inpatients per year; number of changes made in antiretro-
viral medications in the previous one month; and the
level of comfort in managing HIV patients (ranging
between 1 and 5 with 1 = not comfortable and 5 =
extremely comfortable).
The second section included 10 multiple choice questions
derived from commonly encountered antiretroviral med-
ication prescribing errors observed by HIV clinicians and
pharmacists at the two hospitals [3,4]. The questions
assessed knowledge of ART dosing (one question), fre-
quency (three questions), renal dosage adjustment (one
question), drug interactions (four questions) and omis-
sion of an antiretroviral medication (one question). The
questions were reviewed by several ID and non-ID physi-
cians and pharmacists for clarity, interpretability and
accuracy.
The Department of Health and Human Services' Guide-
lines for the Use of Antiretroviral Agents in HIV-1-Infected
Adults and Adolescents were used as the primary reference
to determine if the regimen was correct [10]. Each antiret-
roviral medication-related question was scored with one
point if answered correctly and zero points if answered
incorrectly. At the beginning of the survey, physicians
were informed that it was anonymous and were instructed
not to use external resources to answer questions. The sur-
vey design did not allow skipping of questions, and
respondents could exit the survey at any time.Journal of the International AIDS Society 2009, 12:1 http://www.jiasociety.org/content/12/1/1
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Statistical analysis
Participants were divided into three groups for compari-
son: residents; attending physicians (included non-ID/
HIV specialist attending physicians and non-ID Fellows);
and ID/HIV specialist physicians (included ID fellows, ID
attending physicians and non-ID attendings who identi-
fied themselves as HIV specialists). Mean knowledge
scores were used for different categories of discrete factors
and Pearson correlation coefficients for continuous fac-
tors. Factors in mean knowledge score were analyzed
using Analysis of Covariance [11]. Grouping factors
included: designation as an ID/HIV specialist; physician
type (resident, attending or specialist); number of inpa-
tients and outpatients seen per month; and percent of
inpatients seen per year. Years since completion of resi-
dency, comfort level and number of changes made in the
past month were included as covariates.
Results
Of 343 physicians who received the email request, 179
(52%) completed at least the demographic section of the
survey (98 from BMC and 81 from JHBMC). Physicians
who answered at least one antiretroviral medication-
related question were similar demographically to those
who did not answer any questions. Thus, the 22 physi-
cians who did not answer any of the antiretroviral medi-
cation-related questions were excluded from the analysis
(figure 1).
Respondents included 65 residents, 81 attending physi-
cians and 11 ID/HIV physicians. Of these respondents
142 (90%) answered all 10 questions. Nine answered one
to five questions and six answered six to nine questions.
The respondents who left the survey before completing all
the antiretroviral-related questions were evaluated in two
ways: unanswered questions received a score of zero; and
unanswered questions were not counted. Since both
methods yielded similar results, we report only the per-
centage of answered questions.
Basic demographics of the physicians surveyed are shown
in Table 1. A majority had completed residency training in
the past 10 years. Less than 25% of residents and non-ID/
HIV physicians reported having a comfort level of ≥ 3 for
managing HIV-infected patients, as compared to 100% of
ID/HIV specialists (P < 0.05). Half of all physicians sur-
veyed saw one to five hospitalized HIV patients per
month, whereas 36% of ID/HIV physicians saw ≥ 10 hos-
pitalized HIV patients per month. Less than 10% of resi-
dents and non-ID/HIV attending physicians reported
changing or starting any antiretroviral medications in the
past month compared to 100% of ID/HIV specialists (P <
0.05).
The median score for the antiretroviral medication-related
questions answered correctly was 30% (range = 0–80%)
for both residents and attending physicians compared to
90% (range = 80–100%) for ID/HIV specialist physicians
(Figure 2). Scores were similar across all categories of
errors, except for dosing (Figure 3). Non-ID/HIV physi-
cians as a group scored less than 6% on the dosing ques-
tion (P < 0.05). No difference was found when scores
from BMC and JHBMC were compared (P > 0.9).
Table 2 shows the univariate association of each factor
with knowledge scores. The results of analysis of covari-
ance showed that three factors were significantly related to
HIV knowledge: designation as an ID/HIV specialist (P <
0.001); number of outpatients seen per month (P  <
0.001); and comfort level in managing HIV patients (P <
0.001). These variables combined explained 50% of the
variance in knowledge scores (adjusted r2 = 0.50). The
mean score for ID/HIV specialists was 93%, compared to
only 35% for non-ID/HIV specialists (including residents
and attendings).
There was a trend for scores to increase with increasing
number of inpatient visits but it did not reach statistical
significance (P = 0.10). There was a positive correlation
between number of changes made in medications in the
past month and knowledge scores (r = 0.55). Differences
by training level (ID/HIV specialist, attending or resident)
were accounted for by ID/HIV specialty. There was little
correlation between the number of years since residency
and test performance. (r = 0.128). Flow chart Figure 1
Flow chart.Journal of the International AIDS Society 2009, 12:1 http://www.jiasociety.org/content/12/1/1
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Table 1: Demographic characteristics of survey respondents
Physician type
Characteristic Resident
n = 65 (%)
Non ID/HIV attending physician
n = 81 (%)
ID/HIV physician
n = 11 (%)
No. of years since residency completed
≤ 5 30
(37)
3
(30)
6–10 15
(19)
2
(20)
11–20 23
(28)
5
(50)
> 20 13
(16)
0
Residency level (post-graduate year)
PGY1 21
(32)
PGY2 18
(28)
PGY3 20
(31)
PGY4 6
(9)
1
(100)
No. of HIV inpatients/month
02
(3)
24
(30)
1–5 51
(78)
51
(63)
6
(55)
6–10 12
(18)
4
(5)
1
(9)
11–20 2
(2)
2
(18)
> 20 2
(18)
No. of HIV outpatients/month
03 0
(46)
59
(73)
1–5 31
(48)
16
(20)
2
(18)
6–10 3
(5)
4
(5)
11–20 1
(2)
1
(1)
3
(27)
> 20 1
(1)
6
(55)
% inpatients/yr
1–25% 9
(14)
49
(60)
7
(64)
26–50% 17
(26)
7
(9)
1
(9)
51–75% 28
(43)
6
(7)
1
(9)
76–100% 11
(17)
19
(23)
2
(18)
HIV related "comfort level"
11 8
(28)
23
(28)
23 8
(58)
40
(49)Journal of the International AIDS Society 2009, 12:1 http://www.jiasociety.org/content/12/1/1
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Discussion
HIV/AIDS is now considered a chronic disease, which can
be successfully managed with appropriate use of antiretro-
viral medications in most individuals. Adherence to the
antiretroviral regimen is a major factor in the success of
treatment [8,9]. We found that among non-HIV specialists
who care for hospitalized HIV-infected patients, knowl-
edge of antiretroviral regimens was poor. Furthermore,
knowledge of attending physicians was no better than that
of residents. Few respondents were able to answer more
than 40% of questions correctly, and knowledge of dosing
was particularly poor. In contrast, ID/HIV specialists had
excellent knowledge, as indicated by better scores, and
always identified incomplete drug regimens.
Prior studies have demonstrated that levels of adherence
of 95% or greater are required to prevent regimen failure
due to the development of viral resistance [9]. Histori-
cally, efforts have focused on ART adherence in the outpa-
tient setting. However, it is also important to ensure that
correct ART medications are dispensed during hospitaliza-
tion and particularly at discharge, since patients may con-
tinue incorrect regimens without the knowledge of their
HIV providers.
Without sufficient knowledge of rapidly changing antivi-
ral regimens, hospital physicians, who rarely initiate or
change antiviral therapy, must rely in most cases on
patients' recollection of their regimens, which may not be
accurate. Previous studies done at our hospitals found
38
(12)
15
(19)
4
(36)
41
(2)
3
(4)
2
(18)
5 5
(45)
No. of changes/start of HIV medications in past month
05 9
(91)
73
(90)
0
1–2 4
(6)
6
(7)
2
(18)
≥ 32
(3)
2
(2)
9
(82)
Table 1: Demographic characteristics of survey respondents (Continued)
Mean score (percent of survey questions answered correctly) for residents, attendings and ID/HIV physicians Figure 2
Mean score (percent of survey questions answered correctly) for residents, attendings and ID/HIV physicians.Journal of the International AIDS Society 2009, 12:1 http://www.jiasociety.org/content/12/1/1
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that 21% to 26% of HIV patients experienced ART pre-
scribing errors during the hospitalization [3,4].
Because of the large number of prescribers, each with a
small number of patients, as well as frequently changing
regimens, educational interventions aimed at hospital
physicians are not practical. One potential solution is
mandatory consultation with an ID/HIV specialist. Previ-
ous studies have shown that HIV-specific knowledge is
strongly associated with HIV caseload [12], and that non-
infectious disease HIV specialists perform as well as Infec-
tious Disease physicians [12-15]. Both of these findings
were also observed in our study.
Similarly, we found that ID/HIV physicians made fewer
errors than non-ID/HIV physicians while managing hypo-
thetical hospitalized HIV patients, which to our knowl-
edge, has not been previously demonstrated. Partly in
response to our experience with HIV prescribing errors, we
have implemented mandatory ID consultation for all
HIV-infected inpatients.
Another intervention to decrease ART errors is the use of a
standardized antiretroviral order set. We have recently
implemented such an order set, in which standardized
doses and ART regimens are suggested during the ordering
process. Unusual doses or ART combinations have to be
ordered separately in an attempt to minimize errors. This
system appears to have resulted in fewer errors (unpub-
lished data).
Clinical pharmacists trained in HIV may be able to pre-
vent and mitigate ART errors by "catching" them early,
hopefully before any harm is done. HIV clinical pharma-
cists may also be helpful educational resources for resi-
Mean score (percent of survey questions answered correctly) for residents, attendings and ID/HIV physicians based on the cat- egory of errors Figure 3
Mean score (percent of survey questions answered correctly) for residents, attendings and ID/HIV physicians 
based on the category of errors.
Table 2: Factors associated with correct survey answers: 
univariate analysis
Demographics Mean Score P value*
Specialty
ID/HIV physicians (n = 11) 93% < 0.05
Non-ID/HIV physicians (n = 146) 35%
No. of years since residency
≤ 10 44% 0.79
> 10 42%
No. of HIV inpatients/month
≤ 5 37% < 0.05
> 5 55%
No. of HIV outpatients/month
≤ 5 35% < 0.05
> 5 72%
Comfort level
1–2 33% < 0.05
> 2 58%
Survey site
BMC (n = 82) 39% > 0.9
JHMBC (n = 75) 39%
* calculated by t-testJournal of the International AIDS Society 2009, 12:1 http://www.jiasociety.org/content/12/1/1
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dents and attending physicians while making decisions
about ART medications. At our hospital, an HIV clinical
pharmacist regularly reviews the antiretroviral medication
regimen for HIV-infected inpatients. A study done at our
hospital showed a reduction in duration of antiretroviral-
related errors in hospitalized patients with the interven-
tions of a clinical pharmacist [4].
Our study highlights the difficulties of medication recon-
ciliation when the patient is not certain of their medical
regimen. With the advent of hospitalists, who now care
for the majority of inpatients at most US hospitals, there
is a danger that inappropriate regimens will have started
in the hospital and continued at discharge simply because
the prescribers are unfamiliar with outpatient medica-
tions.
This study had several limitations. First, the small number
of participating ID/HIV physicians may not be represent-
ative of all HIV specialists. However, there was little varia-
tion in the scores of the HIV specialists, and those few
specialists tasked with HIV consults at other institutions
would likely have similar expertise. What is more surpris-
ing is how uniformly low the scores are of the non-HIV
specialists, who do the bulk of HIV prescribing in the hos-
pital.
Second, no information was available for the 164 (48%)
non-responding physicians. It is likely that those who did
not respond would have scored the same or worse than
those who did respond, accentuating the difference seen
between specialists and non-specialists.
Third, our study was limited to two academic hospitals. It
is possible that our results be not be applicable to other
clinical settings. However, our two hospitals were of dif-
ferent sizes, and in different states; yet the knowledge lev-
els based on the survey responses in both were remarkably
similar.
Fourth, our survey has not been validated. Thus, we can
not definitively conclude that clinicians caring for HIV-
infected inpatients should possess this knowledge. How-
ever, the questions were based on previously published
common antiretroviral prescribing errors made by clini-
cians (3, 4). We think it is important for clinicians to rec-
ognize these common scenarios.
Finally, physicians were asked not to use external
resources to search for answers to the questions. In prac-
tice, such resources are available, which may positively
impact on appropriate ART prescribing, and allowance of
the use of such resources may result in better antiretroviral
prescribing knowledge. Indeed, previous studies in both
hospitals found HIV prescribing errors in one quarter of
all HIV admissions.
Antiretroviral prescribing errors seen in hospitalized HIV
patients, including incorrect dosage and incomplete regi-
mens, are common and could lead to antiretroviral resist-
ance. Based on our study, knowledge deficits among non-
HIV specialists may potentially contribute to these errors.
Because educational interventions alone may not be suffi-
cient, consideration should be given to other interven-
tions, such as mandatory ID/HIV consultation,
standardized orders sets, and review by an HIV clinical
pharmacist, in order to decrease the frequency of such
errors. Improvement in information systems that facilitate
the continuation of medications from one setting to
another may also help prevent some of these errors. Fur-
ther studies are warranted to look at the actual or potential
harm resulting from knowledge deficits and analyze the
potential benefits of these interventions.
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Appendix
Appendix 1 – HIV Survey
Demographics
1) What is your specialty?
a. Hospitalist
b. Internal Medicine
c. Family Practice
d. Infectious Diseases
e. Med/Peds
f. Other (please specify)
2) What is your current position?
a. Resident
b. ID fellow
c. Attending physicianJournal of the International AIDS Society 2009, 12:1 http://www.jiasociety.org/content/12/1/1
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3) If you are a resident?
A. Year of residency?
a. R1
b. R2
c. R3
d. R4
3) If you are an attending physician?
a) Do you consider yourself an HIV specialist?
a. Yes
b. No
b) Number of years since you completed your resi-
dency?
a. < 3 years
b. 3–5 years
c. 6–10 years
d. 11–20 years
e. > 20 years
4) How many HIV+ inpatients (new and existing) do you
see per month on average?
a. Zero
b. 1–5
c. 6–10
d. 11–20
e. > 20
5) How many HIV+ outpatients (new and existing) do
you see per month on average?
a. Zero
b. 1–5
c. 6–10
d. 11–20
e. > 20
6) What percentage of time do you spend seeing inpa-
tients per year?
a. 1–25%
b. 26–50%
c. 51–75%
d. 76–100%
7) How comfortable do you feel managing HIV patients,
on a scale of 1 to 5, with 1 being not at all comfortable and
5 being extremely comfortable?
Scale 1–2–3–4–5
8) In the past ONE month, for how many patients have
you initiated or changed antiretroviral medications? ↑
Please choose the singlebest answer:
Questions
Q1. 53 yo HIV+ man is admitted to the hospital for cellu-
litis of the leg. He states he takes Truvada (tenofovir +
emtricitabine) once a day and Sustiva (efavirenz) 200 mg
at bedtime. During the admission it is discovered that he
has hepatitis C with moderate cirrhosis. You should:
a. Continue with current regimen
b. Change Sustiva to 100 mg at bedtime
c. Change Sustiva to 600 mg at bedtime
d. Hold Sustiva
Q2. 41 yo HIV+ man receiving Combivir (zidovudine +
lamivudine) and Viramune (nevirapine) for the past
many years is admitted to the hospital for pneumonia. He
has normal creatinine clearance. The admitting doctor
ordered Combivir 300/150 mg once a day and Viramune
200 mg twice a day. You should:
a. Continue with current regimen
b. Change Viramune to once a day
c. Change Combivir to twice a day
d. Change Combivir to three times a dayJournal of the International AIDS Society 2009, 12:1 http://www.jiasociety.org/content/12/1/1
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Q3. 35 yo HIV+ man presents to ED with a list of herbal
remedies he takes for a variety of medical conditions. His
current medications include: Truvada (tenofovir + emtric-
itabine) and Kaletra (lopinavir + ritonavir). Which of the
following herbal remedies is contraindicated for use with
his current antiretroviral regimen?
a. garlic
b. zinc
c. gingko
d. St. John's wort
e. saw palmetto
Q4. 49 yo HIV+ treatment experienced man reports taking
Combivir (zidovudine + lamivudine) 300/150 mg once a
day, Lexiva (fosamprenavir) 700 mg once a day and Nor-
vir (ritonavir) 200 mg once a day at home. He is admitted
to the hospital for elective cholecystectomy. He has nor-
mal creatinine clearance. You should:
a. Continue with current regimen
b. Hold HIV medications until after surgery
c. Change regimen to Combivir twice a day, Lexiva
700 mg twice a day and Norvir 100 mg twice a day
d. Change regimen to Combivir twice a day and
Lexiva 700 mg twice a day
Q5. 55 yo man is admitted to the ICU with cardiogenic
shock due to myocardial infarction and acute renal fail-
ure. His creatinine clearance is less than 10 ml/minute.
His antiretroviral therapy includes Ziagen (abacavir) 300
mg twice a day, Epivir (lamivudine) 150 mg twice a day
and Sustiva (efavirenz) 600 mg at bedtime. You should:
a. Continue with current regimen
b. Change Ziagen to 150 mg daily
c. Change Epivir to 50 mg daily
d. Change Sustiva to 300 mg daily
Q6. 35 yo HIV+ man former injecting drug user has been
receiving Methadone 50 mg PO daily for past six months.
He is admitted to the hospital at 3 am on Saturday for anx-
iety, vomiting, tachycardia and hypertension. He started
antiretroviral therapy one week ago with Combivir (zido-
vudine + lamivudine) and Sustiva (efavirenz). You are
unable to reach his ID provider over the weekend. You
should recommend:
a. Continuing with current regimen
b. Increasing dose of Methadone
c. Holding Sustiva
d. Holding Combivir
Q7. 61 yo man with h/o hyperlipidemia, diabetes melli-
tus and HIV is admitted to the hospital for uncontrolled
diabetes. He takes Kaletra (lopinavir + ritonavir) and Epz-
icom (abacavir + lamivudine) for HIV and insulin for dia-
betes. All medications are continued. His CD4 count has
been stable around 450 cells/mm with HIV viral load < 50
copies/ml. He is started on atorvastatin 20 mg once a day
for hyperlipidemia in the hospital. You should:
a. Continue with current regimen
b. Change atorvastatin to simvastatin 40 mg
c. Change atorvastatin to lovastatin 40 mg
d. Change Kaletra to ritonavir alone
Q8. 39 yo HIV+ man is admitted to the hospital for an
ankle fracture. He recalls taking Combivir (zidovudine +
lamivudine) 300/150 mg one pill twice a day and Kaletra
(lopinavir + ritonavir) 200/50 mg two pills twice a day at
home. He has normal creatinine clearance. You should:
a. Continue with current regimen
b. Change to Combivir one pill once a day and Kale-
tra one pill once a day
c. Change to Combivir one pill twice a day and Kale-
tra one pill twice a day
d. Change to Combivir one pill twice a day and Kale-
tra three pills twice a day
Q9. 57 yo HIV+ man is admitted to the hospital for
abdominal pain. He has been taking antiretroviral therapy
for one year. Two weeks ago his CD4 count was stable at
350 cells/mm3. On admission the resident orders Reyataz
(atazanavir) 400 mg once a day and Truvada (tenofovir +
emtricitabine) once a day. You should:
a. Continue with current regimen
b. Change Reyataz to 300 mg dailyPublish with BioMed Central    and   every 
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c. Add Norvir (ritonavir) 100 mg daily
d. Change Reyataz to 300 mg daily and add Norvir
(ritonavir) 100 mg daily
Q10. 53 yo HIV + woman admitted for elective knee
replacement. She states she takes one pill for HIV at bed-
time and her HIV viral load has been < 50 copies for sev-
eral months. The medication causes bizarre dreams but
she takes it regularly. The physician's assistant orders Sus-
tiva (efavirenz) on admission. You are called to review her
medications on Friday evening. You should:
a. Continue Sustiva
b. Change to Retrovir (zidovudine) 300 mg at bed-
time
c. Change to Atripla (efavirenz + tenofovir + emtricit-
abine) one pill at bedtime
d. Hold Sustiva until after surgery
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